Advisory Services Network’s Akebia Therapeutics AKBA Stock Holding History

Advisory Services Network’s Portfolio AKBA Stock Details AKBA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-27,000	Closed	-$24.7K	–	1476
2023 Q2	$24.7K	Buy	+27,000	New	+$26.1K	﹤0.01%	1421
2022 Q2	–	Sell	-39,315	Closed	-$28K	–	1375
2022 Q1	$28K	Hold	39,315	–	–	﹤0.01%	1430
2021 Q4	$89K	Hold	39,315	–	–	﹤0.01%	1364
2021 Q3	$113K	Hold	39,315	–	–	﹤0.01%	1329
2021 Q2	$149K	Hold	39,315	–	–	﹤0.01%	1401
2021 Q1	$133K	Hold	39,315	–	–	﹤0.01%	1227
2020 Q4	$110K	Sell	39,315 -500	-1%	-$1.46K	﹤0.01%	1289
2020 Q3	$100K	Buy	39,815 +29,072	+271%	+$255K	﹤0.01%	1260
2020 Q2	$146K	Hold	10,743	–	–	0.01%	975
2020 Q1	$81K	Buy	10,743 +6,439	+150%	+$50.1K	0.01%	1163
2019 Q4	$27K	Buy	+4,304	New	+$20.5K	﹤0.01%	1849

Other funds holding AKBA

AIM

Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Advisory Services Network's AKBA Position: Q3 2023 in Review

Advisory Services Network sold out of Akebia Therapeutics (AKBA) in Q3 2023, closing a stake of 27,000 shares — an estimated $24.7K sold.

Advisory Services Network first reported a position in AKBA in Q4 2019 and held it in 11 quarters. The position peaked at $149K in Q2 2021. 76 funds tracked by Wall St. Rank hold AKBA as of Q3 2023.

Advisory Services Network reported no remaining Akebia Therapeutics position as of Q3 2023 after selling out during the quarter.
Advisory Services Network sold 27,000 Akebia Therapeutics shares in Q3 2023, an estimated $24.7K.
Advisory Services Network first reported a position in Akebia Therapeutics in Q4 2019 and held it in 11 quarters.
Advisory Services Network's Akebia Therapeutics position peaked at $149K in Q2 2021.
76 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q3 2023.

Based on Advisory Services Network's 13F filing for Q3 2023, filed 14 Nov 2023.